Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Stock Price Crosses Below 50 Day Moving Average - What's Next?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient's share price has fallen below its 50-day moving average of $75.50, trading as low as $73.92 recently.
  • Analysts have a consensus rating of "Hold", with Citigroup reissuing a neutral rating and one analyst issuing a strong buy.
  • The company's debt-to-equity ratio stands at 0.77, indicating moderate financial leverage, while its current and quick ratios suggest solid short-term liquidity.
  • Five stocks we like better than Eurofins Scient.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $75.50 and traded as low as $73.92. EUROFINS SCIENT shares last traded at $76.99, with a volume of 1,183 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Citigroup reaffirmed a "neutral" rating on shares of EUROFINS SCIENT in a report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold".

Get Our Latest Research Report on ERFSF

EUROFINS SCIENT Stock Performance

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The stock's 50-day moving average price is $75.74 and its 200-day moving average price is $66.06.

EUROFINS SCIENT Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.